Clinical Outcomes For Patients With Myelofibrosis After Transition From Ruxolitinib To Momelotinib

2025 1:01
Synopsis
Ruben Mesa, MD, Levine Cancer Institute, Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston Salem, NC ...

You Might Also Like

Safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis 3:20
Safety And Anemia Outcomes With Momelotinib Vs Pacritinib In...
2024
COMFORT: Five-Year Outcomes of Ruxolitinib in Patients With Myelofibrosis 3:20
Comfort: Five-year Outcomes Of Ruxolitinib In Patients With ...
2017
Ruxolitinib, pacritinib, fedratinib or momelotinib for thrombocytopenic patients with myelofibrosis 3:05
Ruxolitinib, Pacritinib, Fedratinib Or Momelotinib For Throm...
2023
The promise of momelotinib in the treatment of myelofibrosis 3:00
The Promise Of Momelotinib In The Treatment Of Myelofibrosis
2023
When would you switch a patient with myelofibrosis from ruxolitinib? 3:19
When Would You Switch A Patient With Myelofibrosis From Ruxo...
2022
Phase 3 Trial of Momelotinib Versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis 4:20
Phase 3 Trial Of Momelotinib Versus Ruxolitinib In Jak Inhib...
2018
Update on momelotinib for myelofibrosis 4:25
Update On Momelotinib For Myelofibrosis
2021
Ruben Mesa, MD: Momelotinib Non-Inferior to Ruxolitinib in Myelofibrosis 5:33
Ruben Mesa, Md: Momelotinib Non-inferior To Ruxolitinib In M...
2018
Updates on the use of momelotinib for the treatment of MF & clinical trials evaluating this agent 1:26
Updates On The Use Of Momelotinib For The Treatment Of Mf & ...
2023
Mechanism of Action of Momelotinib to Treat Myelofibrosis 3:38
Mechanism Of Action Of Momelotinib To Treat Myelofibrosis
2023
The latest data on momelotinib for MPNs 4:15
The Latest Data On Momelotinib For Mpns
2022
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.